NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

Another example of scientific understatement, found to jog my memory but since I found it, might as well pass it on since it’s kind of entertaining if one is skewed in a certain way.

When Drucker announced the first experimental results of imatinib on CML, kicking off the era of targeted therapies, published in the journal Nature Medicine, he concluded: “This compound may be useful in the treatment of Bcr-abl positive leukemias.”

From “The Emperor of All Maladies,” p. 435